The focus of the Hepatitis C Association is to educate the public, both patients and medical providers, about hepatitis C virus.
We offer factual information through educational programs and support materials.
We promote awareness of hepatitis C on our website and through our programs, by educating people about the risk factors and the necessity of protecting our livers with treatment of the virus if needed, and/or practicing healthy behaviors through lifestyle changes.
We strive to bring the importance of organ donation to the forefront of the public\'s mind.
We offer support and help with access to patients living with this insidious disease by making information available online, in our brochures, and as the Managing Partner of TSP, through Help-4-Hep a peer-operated toll-free support line.
We strive to minimize the social and personal impact of hepatitis C on the patient.
The Hepatitis C Association, Inc., promises to do its best to help patients in every way possible.
HIVandHepatitis.com coverage of the 15th European AIDS Conference, sponsored by the European AIDS Clinical Society (EACS), October 21-14, 2015, in Barcelona.
Conference highlights include antiretroviral therapy and treatment strategies, new European HIV treatment guidelines, HIV pre-exposure prophylaxis (PrEP), and treatment for hepatitis C
If the world was a village of 1,000 people:
At least 500 would have been infected with hepatitis A, most during childhood.*
200 would have contracted hepatitis E during their lifetimes.
60 would have chronic hepatitis B, most of whom would have contracted it during childhood.
30 would have hepatitis C.
2 would have hepatitis D.
We can eliminate this virus in our lifetime. We have a CURE!
By providing state-of-the-art information and services to address the knowledge gaps in Hepatitis C, we intend to change the course of this urgent public health crisis. We cannot do this without you.
The objective of VHPB is to contribute to the control and prevention of viral hepatitides:
by drawing the attention to this important public health problem
by issuing prevention guidance and catalyse the development of recommendations, and
by encouraging actions to improve control and prevention.
Focus audiences are, in first instance, opinion leaders, policymakers, and health care professionals.
VHPB has, in support of its main objective, a wide range of functions, including the following:
To monitor and evaluate the currently implemented immunisation programmes.
To bring together, during VHPB meetings, an international forum of specialists to examine, discuss, and judge on specific topics, closely related with the control and prevention of viral hepatitis.
To produce and distribute a number of publications, including Viral Hepatitis newsletter, a short reports of VHPB meetings.
To provide guidance and catalyse the development of viral hepatitis control and prevention recommendations/ guidelines for the health care workers and policymakers.
To closely collaborate with international agencies dealing with control and prevention of viral hepatitis (World Health Organisation, Centres of Disease Control and Prevention, European Centre for Disease Prevention and Control, Bill and Melinda Gates Children\'s Vaccine Program, European Commission, and Non Governmental Organisations) in order to maximise the impact of the efforts.
To organise international meetings to facilitate the introduction of immunisation programmes.
To promote the implementation of WHO recommendations on viral hepatitis control and prevention.
To assist implementation of national plans of action for the introduction of vaccines.
When it comes to hepatitis C support, we connect you with helpful information
Infection with the hepatitis C virus (hep C) can last a long time and can eventually cause serious liver problems.
Whether it’s getting tips for talking to your loved ones about hep C, finding the right insurance, or testing your knowledge, you’ll find it here.
You can also sign up to receive additional information. Because we’re dedicated to supporting
A single, online point for prescribing, confirming patient benefits, submitting prior authorizations (PAs), and enrolling a patient for Support Path resources. Registration is fast and easy—sign up today.
Are you uninsured? If you do have health coverage, are your prescription co-pays or other co-insurance costs prohibitively expensive? Or does your plan come with high medication deductibles that you can\'t afford? Help may be available from pharmaceutical companies and other organizations in the form of co-pay programs and patient assistance programs (PAPs).
Need help paying for your OLYSIO® (simeprevir) prescription?
We want to guide you to programs that may help. Here you\'ll find the financial assistance programs available for OLYSIO®. We have also listed most of the eligibility requirements for each so you can narrow your focus to those that best suit your circumstances. Call the programs or visit their web sites to learn more.
This site is for AbbVie U.S. and Puerto Rico Grant and Charitable Donation requests.
The following types of funding requests are supported by this online system:
Medical Education Grants
Accredited programs, including live presentations (e.g., symposia, regional/local programs, teleconferences, live webcasts), and enduring materials (e.g., printed, slide kits, monographs, and web-based instructional materials)
Educational Support Grants Fellowships, Patient education, Screening programs, Scholarships to educational conferences, Third-party educational, scientific or professional meetings
Gilead welcomes funding requests for innovative, high-impact projects that relate to at least one of five core therapeutic areas: HIV/AIDS, liver diseases, hematology and oncology, inflammatory and respiratory diseases, and cardiovascular conditions. We consider a number of factors when reviewing grants, but it is most important for applications to demonstrate a strong commitment to — and capacity for — delivering the specific services your funded grant would support. - See more at: http://www.gilead.com/responsibility/corporate-contributions/north-america/grants-programs#sthash.tKVdXOQg.dpuf
Grants & Giving
Bristol-Myers Squibb is committed to conscientious citizenship and helping worthwhile causes. This principle is the pillar of an extensive – indeed worldwide – scope of charitable activities.
From fighting AIDS in Africa to improving mental health services in rural Alabama, Bristol-Myers Squibb helps make a positive difference throughout the world.
Our giving is administered through a variety of grant-making programs, each with its own focus and application procedure.
Mission Statement: The Coalition for the Homeless of Houston/Harris County is a private, nonprofit organization whose mission is to provide leadership in the development, advocacy, and coordination of community strategies to prevent and end homelessness.
WIC is a free nutrition program that helps pregnant women, new mothers, and young children eat well, learn about nutrition and stay healthy. Nutrition education and counseling, nutritious foods and help accessing health care are provided to middle to low-income women, infants, and children through the Special Supplemental Nutrition Program, popularly known as WIC. U.S. citizenship is not required.
The mission of The Houston Regional HIV/AIDS Resource Group is to maximize all possible medical, psychosocial and educational resources to help persons affected by or at risk of HIV/AIDS nationally with primary focus in east and southeast Texas.
Our responsibilities, as set forth in Our Credo, guide Janssen\'s charitable giving. In administering our philanthropy program, Janssen addresses these responsibilities by encouraging employee volunteerism and involvement in our local communities, as well as by making charitable contributions to nonprofit organizations that are having a positive impact in our local communities and those that are benefiting the patients who use our products and services.